You are here

Pivotal Therapeutics Inc.

Listing Exchange: 
CSE
Status: 
Suspended
Industry: 
Life Sciences
Symbol: 
PVO
CSE Index: 
Currency: 

Pivotal Therapeutics Inc. is a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health. The company currently has two commercial products: VASCAZEN® is available in the US by prescription only and OMAZEN™ is available for sale as a natural health product in Canada.The company's lead product VASCAZEN® is a prescription only Medical Food for the treatment of an Omega-3 Deficiency (OM3D) in patients with cardiovascular disease. The company's second product OMAZEN® is an ultra pure Omega-3 for the maintenance of good health.

You are here

Pivotal Therapeutics Inc. (PVO)

SEDAR Information

Pivotal Therapeutics Inc.
Date: May 6, 2016
Pivotal Therapeutics Inc.
Date: November 30, 2015
Pivotal Therapeutics Inc.
Date: November 30, 2015
Pivotal Therapeutics Inc.
Date: November 30, 2015
Pivotal Therapeutics Inc.
Date: November 30, 2015
Pivotal Therapeutics Inc.
Date: November 20, 2015
Pivotal Therapeutics Inc.
Date: November 20, 2015
Pivotal Therapeutics Inc.
Date: November 5, 2015
Pivotal Therapeutics Inc.
Date: October 8, 2015
Pivotal Therapeutics Inc.
Date: September 28, 2015
Pivotal Therapeutics Inc.
Date: September 22, 2015
Pivotal Therapeutics Inc.
Date: August 31, 2015
Pivotal Therapeutics Inc.
Date: August 28, 2015
Pivotal Therapeutics Inc.
Date: August 28, 2015
Pivotal Therapeutics Inc.
Date: August 28, 2015
Pivotal Therapeutics Inc.
Date: August 28, 2015
Pivotal Therapeutics Inc.
Date: July 21, 2015
Pivotal Therapeutics Inc.
Date: June 18, 2015
Pivotal Therapeutics Inc.
Date: June 4, 2015
Pivotal Therapeutics Inc.
Date: June 2, 2015
Pivotal Therapeutics Inc.
Date: June 2, 2015
Pivotal Therapeutics Inc.
Date: June 2, 2015
Pivotal Therapeutics Inc.
Date: June 2, 2015
Pivotal Therapeutics Inc.
Date: June 2, 2015
Pivotal Therapeutics Inc.
Date: June 2, 2015
Pivotal Therapeutics Inc.
Date: June 1, 2015
Pivotal Therapeutics Inc.
Date: June 1, 2015
Pivotal Therapeutics Inc.
Date: June 1, 2015
Pivotal Therapeutics Inc.
Date: June 1, 2015
Pivotal Therapeutics Inc.
Date: June 1, 2015
Pivotal Therapeutics Inc.
Date: May 11, 2015
Pivotal Therapeutics Inc.
Date: May 1, 2015
Pivotal Therapeutics Inc.
Date: April 30, 2015
Pivotal Therapeutics Inc.
Date: April 30, 2015
Pivotal Therapeutics Inc.
Date: April 30, 2015
Pivotal Therapeutics Inc.
Date: April 30, 2015
Pivotal Therapeutics Inc.
Date: April 30, 2015
Pivotal Therapeutics Inc.
Date: April 27, 2015
Pivotal Therapeutics Inc.
Date: April 15, 2015
Pivotal Therapeutics Inc.
Date: April 7, 2015
Pivotal Therapeutics Inc.
Date: April 1, 2015
Pivotal Therapeutics Inc.
Date: March 26, 2015
Pivotal Therapeutics Inc.
Date: February 10, 2015
Pivotal Therapeutics Inc.
Date: January 27, 2015
Pivotal Therapeutics Inc.
Date: January 22, 2015
Pivotal Therapeutics Inc.
Date: January 5, 2015

Company Info

Address
81 Zenway Blvd Unit 10
Woodbridge, ON L4H 0S5
Canada
Phone
1-905-8569797
Fax
1-905-8562177
Email
EBortoluzzi@pivotaltherapeutics.us
Website
http://www.pivotaltherapeutics.us
Listing date
Thursday, May 19, 2011
Investor Relations
Pivotal Therapeutics Inc.
Auditor
MNP LLP.

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
96566669
Reserved for Issuance: 
10680384

Bulletins

17/08/2016

2016-0819 - Suspension - Pivotal Therapeutics Inc. (PVO)

August 17, 2016

Pivotal Therapeutics Inc. is in default of CSE requirements. Effective at market close, Pivotal Therapeutics, currently the subject of a Cease Trade Order, will be suspended pursuant to CSE Policy 3. The suspension is considered a Regulatory Halt as defined in National Instrument 23-101 Trading Rules.

Date: Effective market close, August 17, 2016
Symbol: PVO